Advance Search
Volume 38 Issue 12
Dec.  2022
Turn off MathJax
Article Contents
DAI Se-ying, LIU Ai-wen, JIN Lin, . Survival time and related factors among child HIV/AIDS patients in Anhui province[J]. Chinese Journal of Public Health, 2022, 38(12): 1588-1592. doi: 10.11847/zgggws1137822
Citation: DAI Se-ying, LIU Ai-wen, JIN Lin, . Survival time and related factors among child HIV/AIDS patients in Anhui province[J]. Chinese Journal of Public Health, 2022, 38(12): 1588-1592. doi: 10.11847/zgggws1137822

Survival time and related factors among child HIV/AIDS patients in Anhui province

doi: 10.11847/zgggws1137822
  • Received Date: 2021-12-24
    Available Online: 2022-08-31
  • Publish Date: 2022-12-10
  •   Objective  To examine the survival time of child human immunodeficiency virus (HIV)/AIDS patients and its influencing factors in Anhui province.   Methods  Follow-up and medication information on all laboratory confirmed AIDS patients aged ≤ 15 years at the diagnosis and being permanent residents of Anhui province were collected from National Comprehensive HIV/AIDS Information Management System up to the end of 2020 and analyzed retrospectively. The survival rate was calculated with life table method and impact factors of survival were assessed using Cox regression model.   Results  Among a total of 329 child HIV/AIDS patients being followed-up during the period, 54 died of AIDS-related diseases and the mortality rate was 2.2/100 person-years. The results of Cox proportional hazards regression analysis showed that for all the child patients, the children with AIDS at the time of first diagnosis and not receiving antiretroviral therapy were at a significantly higher risk of AIDS-related disease mortality, with the hazard ratio (HR) of 5.32 (95% confidence interval [95% CI] : 2.70 – 10.47) and 28.29 (95% CI : 14.63 – 54.70) compared to those not having AIDS at the first diagnosis and to those receiving antiretroviral therapy; among the child patients with antiretroviral therapy, the risk of AIDS-related disease mortality were significantly higher for those aged < 5 years at the first diagnosis (versus aged 11 – 15 years: HR = 6.18, 95% CI : 14.63 – 54.70 ), having AIDS at the first diagnosis (versus having HIV infection: HR = 5.07, 95% CI : 1.27 – 20.29), and with the baseline CD4 + T lymphocyte count of < 50 cells/μL (HR = 10.99, 95% CI : 2.04 – 59.20) or 50 – 200 cells/μL (HR = 8.40, 95% CI : 1.35 – 52.26) compared to the child patients with the baseline count of > 200 cells/μL, respectively.   Conclusion  Among child HIV/AIDS patients in Anhui province, antiretroviral therapy is an important factor for survival and the baseline CD4 + T lymphocyte count is the key factor affecting the effect of antiretroviral therapy.
  • loading
  • [1]
    苏普玉, 陶芳标, 郝加虎, 等. 安徽农村地区曾因有偿献血感染HIV/AIDS的已婚成人心理卫生问题研究[J]. 卫生研究, 2010, 39(6): 739 – 742,746.
    [2]
    Kaufman J, Jing J. China and AIDS – the time to act is now[J]. Science, 2002, 296(5577): 2339 – 2340. doi: 10.1126/science.1074479
    [3]
    周信娟, 沈智勇, 阮玉华, 等. 经母婴传播艾滋病患者生存分析[J]. 中国公共卫生, 2018, 34(7): 964 – 967.
    [4]
    杨壁珲, 张米, 舒远路, 等. 云南省接受抗病毒治疗的艾滋病患儿10年死亡风险及其预测因素分析[J]. 中华传染病杂志, 2019, 37(1): 28 – 31.
    [5]
    Njom Nlend AE, Loussikila AB. Predictors of mortality among HIV - infected children receiving highly active antiretroviral therapy[J]. Médecine et Maladies Infectieuses, 2017, 47(1): 32 – 37.
    [6]
    尹浩, 马烨, 杨萱, 等. 我国14岁及以下HIV感染儿童生存分析[J]. 中华流行病学杂志, 2020, 41(6): 850 – 855. doi: 10.3760/cma.j.cn112338-20191129-00844
    [7]
    陈亮, 张明雅, 严延生. 福建省2003 — 2015年儿童HIV/AIDS病例生存时间分析[J]. 中国公共卫生, 2016, 32(12): 1605 – 1608. doi: 10.11847/zgggws2016-32-12-01
    [8]
    Chaimay B, Woradet S, Chantutanon S, et al. Clinical risk factors on survival among HIV - infected children born to HIV - infected mothers[J]. Journal of the Medical Association of Thailand, 2013, 96(11): 1434 – 1443.
    [9]
    Arage G, Assefa M, Worku T, et al. Survival rate of HIV - infected children after initiation of the antiretroviral therapy and its predictors in Ethiopia: a facility - based retrospective cohort[J]. SAGE Open Medicine, 2019: 7. doi: 10.1177/2050312119838957
    [10]
    杨薇, 栾荣生, 赖文红, 等. 2007 — 2013年四川省355例艾滋病儿童患者抗病毒治疗情况分析[J]. 预防医学情报杂志, 2018, 34(2): 227 – 231.
    [11]
    孙定勇, 杨文杰, 马彦民, 等. 2003 — 2014年河南省14岁及以下艾滋病抗病毒治疗患者生存分析[J]. 中华预防医学杂志, 2015, 49(8): 700 – 704. doi: 10.3760/cma.j.issn.0253-9624.2015.08.007
    [12]
    Somi G, Majigo M, Manyahi J, et al. Pediatric HIV care and treatment services in Tanzania: implications for survival[J]. BMC Health Services Research, 2017, 17(1): 540. doi: 10.1186/s12913-017-2492-9
    [13]
    Melaku Z, Lulseged S, Wang CH, et al. Outcomes among HIV - infected children initiating HIV care and antiretroviral treatment in Ethiopia[J]. Tropical Medicine and International Health, 2017, 22(4): 474 – 484. doi: 10.1111/tmi.12834
    [14]
    Sandgaard KS, Lewis J, Adams S, et al. Antiretroviral therapy increases thymic output in children with HIV[J]. AIDS, 2014, 28(2): 209 – 214. doi: 10.1097/QAD.0000000000000063
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(2)

    Article views (332) PDF downloads(31) Cited by()
    Proportional views
    Publishing history
    • Receive:  2021-12-24
    • Online:  2022-08-31
    • Published:  2022-12-10

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return